MD Anderson Team Wins NIH Grant for Pancreatic Cancer Biomarker Study | GenomeWeb

NEW YORK (GenomeWeb) – The National Institutes of Health has awarded an MD Anderson Cancer Center team a one-year grant to follow up on preliminary data suggesting that certain microRNAs can be used as biomarkers to identify pancreatic neoplasms at high risk for progressing into invasive tumors.

Intraductal papillary mucinous neoplasms, or IPMNs, are cystic lesions that frequently, but not always, progress into pancreatic ductal adenocarcinoma (PDAC).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.